FDA gives emergency approval to COVID-19 antibody serum used to treat Trump
The approval of Regeneron’s treatment is second in a month.
The Food and Drug Administration on Saturday evening gave emergency approval for a COVID-19 antibody treatment used to treat President Trump.
Regeneron’s antibody serum was authorized for treating mild to moderate coronavirus in adults, as well as children 12 years or older who have a high risk of progressing to severe disease.
Regeneron applied for emergency FDA approval in October after Trump praised the treatment in a Twitter video.
The FDA earlier this month also issued an emergency use authorization for another COVID-19 antibody treatment made by Eli Lilly.
News, Not Noise
- Trump touts his record, says media would have a 'field day' if he let crime, COVID get out of hand
- Hillary Clinton's old campaign law firm uses China excuse to avoid Carter Page lawsuit
- Fox 'parts ways' with Napolitano after employee sues, alleging misconduct by judge and Kudlow
- Feds inventing 'absurd' excuses like obesity to release illegals, whistleblower tells Congress
- Rhode Island investigates school district for banning public from antiracism policy discussions